A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ

Journal of the National Cancer Institute

Volumn 105, Issue 10, 2013, Pages 681-683

  Duggal, Shivani ^a   Julian, Thomas B ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ALGORITHM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; DRUG USE; EDITORIAL; EXCISION; GENE EXPRESSION; GENETIC SCREENING; HUMAN; INTRADUCTAL CARCINOMA; IPSILATERAL BREAST TUMOR RECURRENCE; MAMMOGRAPHY; MASTECTOMY; MULTIGENE EXPRESSION ASSAY; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM RECURRENCE, LOCAL;

EID: 84877945635     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt098     Document Type: Editorial

References (24)

1. Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443-448.
2. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546-1554.
3. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer. 1999;85(3): 616-628.
4. Rashtian A, Iganej S, Amy Liu I-L A, et al. Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy. Int J Radiation Oncology Biol Phys. 2008;72(4):1016-1020.
5. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16(2):441-452.
6. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intra-ductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999(9169);353:1993-2000.
7. Julian T, Land S, Wolmark N. NSABP B-35: a clinical trial to compare anastrozole and tamoxifen for postmenopausal patients with ductal carcinoma in situ undergoing lumpectomy with radiation therapy. Breast Dis Yearbook Q. 2003;14(2):121-122.
8. NSABP B-43. Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy. http://www.cancer.gov/clinicaltrials/search/view?cdrid=615085&version= HealthProfessional. Accessed March 15, 2013.
9. Silverstein MJ. Ductal carcinoma of the breast: 11 reasons to consider treatment with excision alone. Womens Health (Lond Engl). 2008;4(6):565-577.
10. Solin, LJ. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;41(2):187-192.
11. Smith GL, Smith BD, Haffty BG. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2006;65(5):1397-1403.
12. Wong J, Kaelin C, Troyan S et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;34(7):1031-1036.
13. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162- 177.
14. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478-488.
15. Allred DC, Anderson SJ, Paik S, et al. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 2012;30(12):1268-1273.
16. Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet. 2003;362(9378):95-102.
17. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86(3):429-438.
18. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 2001;28(4):400-418.
19. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381-3387.
20. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26(8): 1247-1252.
21. Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319-5324.
22. RTOG 9804. Results at ASTRO 2012: Radiotherapy for "Good Risk" DCIS. http://www.rtog.org/News/tabid/72/articleType/ArticleView/arti-cleId/47/ RTOG-9804-Results-at-ASTRO-2012-Radiotherapy-for-Good-Risk-DCIS.aspx. Accessed March 15, 2013.
23. Solin LJ, Gray R, Baehner FL, et al. A multigene expression assay to predict local recurrence risk for DCIS of the breast. J Natl Cancer Inst. 2013;105(10):xx-xx.
24. Allred DC, Clark GM, Tandon AK, et al. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol. 1992;10(4):599-605.